As independent prognostic factors, ApoA-1 and CRP can be used to reflect the OS and DFS of HCC patients, which prompted us to develop a prognostic grouping system to better reflect the actual outcomes of patients with HCC. The gene discussed is CRP; the disease is hepatocellular carcinoma.